Finally, molecular docking and dynamics simulations validated the hypothesis that YFSJF inhibits PIK3R1, PIK3CA, and AKT1 to suppress the PI3K/AKT pathway and fight NSCLC. Here, AKT1 is linked to non-small cell lung carcinoma.